Visteon shares jumped 15% this week to $113.69, capping a 30% month as Q1 earnings beat expectations and analysts lifted targets across the board. Short interest fell 9%, utilization sits near multi-month lows, and options traders flipped bullish.
VC closed at $113.69 on April 24, up 3.9% on the day. The stock gained 15.2% over the past week and has rallied 29.6% in the last month. The automotive cockpit-electronics supplier has broken out from its early-March range below $90.
Short interest stands at 2.64 million shares, representing 9.7% of the float as of April 23. Shares short declined 1.7% over the prior day and fell 0.7% across the week. Over the past month short interest rose 8.9%, but that climb predated the late-March rally. The position peaked at 2.79 million shares on April 6, the highest since mid-March.
Cost to borrow registered 0.45% APR on April 23, down 2.8% week-on-week and up 6.6% over 30 days. The rate spiked to 0.50% on March 26, then eased through early April and has hovered in the 0.43–0.49% band since.
Utilization sat at 14.2% on April 23, well below the 52-week high of 27.1%. The reading has bounced between 11% and 15.5% over the past month, dipping to 11% on April 15 before ticking up. The current level is toward the lower end of the recent range.
Put/call ratio dropped to 0.072 on April 24, the 52-week low. The 20-day mean is 0.21, giving a z-score of –2.74. Call volume dominated as traders bet on further upside. The PCR had ranged between 0.15 and 0.29 through mid-April before collapsing after earnings. The 52-week high of 2.60 was registered in early March.
Analysts have a mean price target of $117.36, implying 3.2% upside from the April 24 close. Following the April 23 earnings release, four firms raised targets in 24 hours.
UBS analyst Joseph Spak lifted his Buy-rated target to $130 from $120 on April 24. Goldman Sachs analyst Mark Delaney raised his Buy target to $118 from $106 the same day. Baird's Luke Junk boosted his Outperform target to $121 from $112. JP Morgan's Ryan Brinkman, rated Neutral, trimmed his target to $108 from $110 on April 23.
Earlier revisions were downward. In February, UBS cut to $120 from $130, Wells Fargo moved to $125 from $148, Baird went to $119 from $126, and RBC Capital lowered to $127 from $140. Those adjustments followed weaker Q2 2024 revenue and EV headwinds.
The price/earnings ratio rose to 12.56 on April 24, up 2.69 points over 30 days as the share price outpaced earnings revisions. The price/book multiple climbed to 1.69, a 0.35-point gain over the month. EV/EBITDA expanded to 5.50, adding 0.51 points over 30 days.
Visteon ranks in the 87th percentile for dividend score, reflecting the 2015–2016 special distributions. The stock sits in the 82nd percentile for sector score and 75th for EV/EBIT. Earnings momentum is cooler, with 30-day EPS momentum at the 20th percentile and 90-day at the 15th. EPS surprise ranks at the 36th percentile. The short score rank of 15 indicates few shorts relative to the broader market.
American Century added 88,897 shares in the quarter ended March 31, bringing its stake to 2.08 million shares (7.8% of the company). Dimensional Fund Advisors boosted its position by 175,679 shares to 1.40 million (5.2%). Victory Capital increased by 187,347 shares to 1.33 million (5.0%).
BlackRock added 123,228 shares to 3.55 million (13.2%). Vanguard lifted its holding by 106,598 shares to 2.82 million (10.5%). Both are passive index managers. Allianz Asset Management surged by 363,064 shares to 437,403 as of year-end 2025.
Insiders sold a net 3,420 shares over the past 90 days, worth $304,783. All recent transactions were small tax-related sales tied to equity vesting on March 13 and March 16. CEO Sachin Lawande sold 59 shares at $90.06 on March 16 for $5,314. CFO Jerome Rouquet sold 11 shares for $991. SVP Robert Vallance sold 344 shares at $89.09 for $30,647 on March 13, also receiving a 1,393-share award the same day. The transactions represented less than 0.01% of the company in each case and carried trade significance of 1 out of 10.
Top correlated peers include Aptiv, Lear, and Gentex. Aptiv fell 2.1% over the past week while Visteon climbed 15.2%. Lear rose 1.8% in the same window. The divergence reflects Visteon's strong Q1 print and improved sentiment on its Japanese OEM wins and China expansion, themes highlighted in recent analyst commentary.
Visteon had four earnings events logged for April 23, 2026. Historical price-reaction data is not available in the snapshot.
No next earnings event is scheduled yet. Investors will monitor updates on new program launches with Toyota, production ramp in China, and any guidance revisions tied to global auto volumes. The stock has regained momentum after the Q2 2024 revenue miss, and the options market is pricing in continued strength.
See the live data behind this article on ORTEX.
Open VC on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
